<?xml version="1.0" encoding="UTF-8"?>
<ref id="B16-pharmaceutics-11-00021" class="ref">
 <label class="label">16.</label>
 <element-citation publication-type="journal" class="element-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Badens</surname>
    <given-names class="given-names">E.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Masmoudi</surname>
    <given-names class="given-names">Y.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Mouahid</surname>
    <given-names class="given-names">A.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Crampon</surname>
    <given-names class="given-names">C.</given-names>
   </name>
  </person-group>
  <article-title class="article-title">Current situation and perspectives in drug formulation by using supercritical fluid technology</article-title>
  <source class="source">J. Supercrit. Fluids</source>
  <year class="year">2018</year>
  <volume class="volume">134</volume>
  <fpage class="fpage">274</fpage>
  <lpage class="lpage">283</lpage>
  <pub-id pub-id-type="doi" class="pub-id">10.1016/j.supflu.2017.12.038</pub-id>
 </element-citation>
</ref>
